Cambridge, MA, United States of America

Tisento Therapeutics Inc.


USPTO Granted Patents = 5


Forward Citations = 0

Loading Chart...
Loading Chart...

18 inventors (with patents filed for the assignee):

goldMedal Takashi Nakai (2 out of 23 patents)

silverMedal Ara Mermerian (2 out of 18 patents)

bronzeMedal Glen Robert Rennie (2 out of 32 patents)

4.  Paul A Renhowe (2 out of 59 patents)

5.  Thomas Storz (2 out of 4 patents)

6.  G-Yoon Jamie Im (1 out of 13 patents)

7.  Rajesh R Iyengar (1 out of 26 patents)

8.  Thomas Wai-Ho Lee (1 out of 17 patents)

9.  Lei Jia (1 out of 15 patents)

10.  Karthik Iyer (1 out of 10 patents)

11.  Joon Jung (1 out of 23 patents)

12.  Timothy Claude Barden (1 out of 19 patents)

13.  Peter Germano (1 out of 4 patents)

14.  Kim Tang (1 out of 5 patents)

15.  Kwame Wiredu Nti-Addae (1 out of 9 patents)


5 patents:

Company Overview
Tisento Therapeutics Inc. is a biotechnology company focused on developing innovative therapies for autoimmune diseases and other serious conditions. The company leverages advanced technologies to create targeted treatments that aim to improve patient outcomes. With a commitment to scientific excellence and patient-centric approaches, Tisento is dedicated to addressing unmet medical needs through its research and development efforts.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

5 Patents

#368 in Cambridge, MA

#2,892 in Massachusetts

#51,570 in US

Cambridge, MA (US)
Cambridge, MA, United States of America
Forward Citations = 0

18 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Tisento Therapeutics Inc.. Retrieved from https://idiyas.com/company/tisento-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…